{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:14:29Z","timestamp":1792588469362,"version":"4.5.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ajog.2020.09.038","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T13:56:28Z","timestamp":1601042188000},"page":"S1059-S1070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"S","title":["Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome"],"prefix":"10.1016","volume":"226","author":[{"given":"Richard M.","family":"Burwick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce B.","family":"Feinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2020.09.038_bib1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molimm.2015.02.030","article-title":"The complement system and adverse pregnancy outcomes","volume":"67","author":"Regal","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41577-019-0168-x","article-title":"New insights into the immune functions of complement","volume":"19","author":"Reis","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4049\/jimmunol.118.1.83","article-title":"Complement activation by interaction of polyanions and polycations. III. Complement activation by interaction of multiple polyanious and polycations is the presence of C-reactive protein","volume":"118","author":"Claus","year":"1977","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib5","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4049\/jimmunol.1000184","article-title":"Cutting edge: C1q binds deoxyribose and heparan sulfate through neighboring sites of its recognition domain","volume":"185","author":"Garlatti","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib6","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.4049\/jimmunol.146.7.2324","article-title":"Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q","volume":"146","author":"Jiang","year":"1991","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib7","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R","article-title":"Direct binding of C1q to apoptotic cells and cell blebs induces complement activation","volume":"32","author":"Nauta","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib8","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4049\/jimmunol.164.5.2281","article-title":"Cutting edge: complement-activating complex of ficolin and mannose-binding lectin-associated serine protease","volume":"164","author":"Matsushita","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/imr.12475","article-title":"Protection of host cells by complement regulators","volume":"274","author":"Schmidt","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ajog.2020.09.038_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0140-6736(73)91886-2","article-title":"Reaction mechanism of the alternative pathway of complement fixation","volume":"1","author":"Lachmann","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.09.038_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0065-2776(08)04004-2","article-title":"The amplification loop of the complement pathways","volume":"104","author":"Lachmann","year":"2009","journal-title":"Adv Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1084\/jem.127.2.371","article-title":"The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement","volume":"127","author":"Cochrane","year":"1968","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ajog.2020.09.038_bib13","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1073\/pnas.76.10.5299","article-title":"C4a: the third anaphylatoxin of the human complement system","volume":"76","author":"Gorski","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajog.2020.09.038_bib14","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1073\/pnas.69.10.2954","article-title":"Mechanism of cytolysis by complement","volume":"69","author":"Mayer","year":"1972","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajog.2020.09.038_bib15","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1073\/pnas.72.12.5076","article-title":"On the mechanism of cytolysis by complement: evidence on insertion of C5b and C7 subunits of the C5b,6,7 complex into phospholipid bilayers of erythrocyte membranes","volume":"72","author":"Hammer","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajog.2020.09.038_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/14767050500072722","article-title":"Normal pregnancy is characterized by systemic activation of the complement system","volume":"17","author":"Richani","year":"2005","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.09.038_bib17","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.molimm.2010.01.021","article-title":"Activation of the complement system in normal pregnancy and preeclampsia","volume":"47","author":"Derzsy","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1600-0897.2005.00362.x","article-title":"Preeclampsia: the death of Goliath","volume":"55","author":"Feinberg","year":"2006","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9378(97)70438-1","article-title":"Placental apoptosis in normal human pregnancy","volume":"177","author":"Smith","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.09.038_bib20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.09.038_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1749-6632.2001.tb03887.x","article-title":"Circulating fetal RNA in maternal plasma","volume":"945","author":"Poon","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ajog.2020.09.038_bib22","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/266542a0","article-title":"Circulating immune complexes in normal human pregnancy","volume":"266","author":"Masson","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2020.09.038_bib23","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/eji.1830220635","article-title":"Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55)","volume":"22","author":"Holmes","year":"1992","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib24","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.144.8.3099","article-title":"Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy","volume":"144","author":"Holmes","year":"1990","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0165-0378(91)90036-P","article-title":"Differential expression of complement regulatory proteins on subpopulations of human trophoblast cells","volume":"19","author":"Hsi","year":"1991","journal-title":"J\u00a0Reprod Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib26","doi-asserted-by":"crossref","first-page":"e13202","DOI":"10.1111\/aji.13202","article-title":"Normal range of complement components during pregnancy: a prospective study","volume":"83","author":"He","year":"2020","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib27","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3389\/fimmu.2014.00312","article-title":"Complement activation and regulation in preeclamptic placenta","volume":"5","author":"Lokki","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mce.2019.04.006","article-title":"Endovascular trophoblast expresses CD59 to evade complement-dependent cytotoxicity","volume":"490","author":"Ueda","year":"2019","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ajog.2020.09.038_bib29","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.09.038_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0002-9378(16)32330-4","article-title":"Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy","volume":"142","author":"Weinstein","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.09.038_bib31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00003081-195806000-00007","article-title":"Pathology of the placenta in toxemia","volume":"1","author":"Nesbitt","year":"1958","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.09.038_bib32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0002-9378(16)36717-5","article-title":"Some observations on the placental factor in pregnancy toxemia","volume":"77","author":"Jeffcoate","year":"1959","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.09.038_bib33","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1172\/JCI116316","article-title":"Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts","volume":"91","author":"Zhou","year":"1993","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2020.09.038_bib34","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1172\/JCI118447","article-title":"Hypoxia alters early gestation human cytotrophoblast differentiation\/invasion in\u00a0vitro and models the placental defects that occur in preeclampsia","volume":"97","author":"Genbacev","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2020.09.038_bib35","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.4049\/jimmunol.178.9.5949","article-title":"Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles","volume":"178","author":"Germain","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib36","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: an endothelial cell disorder","volume":"161","author":"Roberts","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.09.038_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/plac.2002.0903","article-title":"Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation","volume":"24","author":"Huppertz","year":"2003","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2020.09.038_bib38","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1073\/pnas.90.22.10705","article-title":"Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor","volume":"90","author":"Kendall","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajog.2020.09.038_bib39","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1006\/bbrc.1994.1705","article-title":"Specificity of vascular endothelial cell growth factor receptor ligand binding domains","volume":"201","author":"Kendall","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajog.2020.09.038_bib40","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2020.09.038_bib41","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.09.038_bib42","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.placenta.2008.07.008","article-title":"The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in\u00a0vivo and modulates human trophoblast function in\u00a0vitro","volume":"29","author":"Rampersad","year":"2008","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2020.09.038_bib43","doi-asserted-by":"crossref","first-page":"e13033","DOI":"10.1111\/aji.13033","article-title":"Upregulation and release of soluble fms-like tyrosine kinase receptor 1 mediated by complement activation in human syncytiotrophoblast cells","volume":"80","author":"Banadakoppa","year":"2018","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/10641955.2019.1640725","article-title":"Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia","volume":"38","author":"Yonekura Collier","year":"2019","journal-title":"Hypertens Preg"},{"key":"10.1016\/j.ajog.2020.09.038_bib45","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/HYPERTENSIONAHA.112.194324","article-title":"Preeclampsia is characterized by placental complement dysregulation","volume":"60","author":"Buurma","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.09.038_bib46","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.placenta.2004.05.004","article-title":"Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta","volume":"26","author":"Li","year":"2005","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2020.09.038_bib47","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1210\/en.2004-0533","article-title":"Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia","volume":"145","author":"Nagamatsu","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajog.2020.09.038_bib48","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1084\/jem.20061022","article-title":"Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction","volume":"203","author":"Girardi","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ajog.2020.09.038_bib49","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1182\/blood-2010-01-261503","article-title":"Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis","volume":"116","author":"Langer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2020.09.038_bib50","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/jcmm.13466","article-title":"Complement 5a-mediated trophoblasts dysfunction is involved in the development of pre-eclampsia","volume":"22","author":"Ma","year":"2018","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.ajog.2020.09.038_bib51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.med.59.060106.185110","article-title":"Complement regulatory genes and hemolytic uremic syndromes","volume":"59","author":"Kavanagh","year":"2008","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ajog.2020.09.038_bib52","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ajog.2020.09.038_bib53","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2215\/CJN.00280117","article-title":"Hemolytic uremic syndrome in pregnancy and postpartum","volume":"12","author":"Bruel","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ajog.2020.09.038_bib54","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations","volume":"21","author":"Fakhouri","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ajog.2020.09.038_bib55","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/AOG.0000000000003554","article-title":"Pregnancy-associated atypical hemolytic uremic syndrome: a systematic review","volume":"135","author":"Gupta","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.09.038_bib56","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.4049\/jimmunol.1701695","article-title":"Statistical validation of rare complement variants provides insights into the molecular basis of atypical hemolytic uremic syndrome and C3 glomerulopathy","volume":"200","author":"Osborne","year":"2018","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2015.03.246","article-title":"Atypical aHUS: state of the art","volume":"67","author":"Nester","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib58","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","article-title":"Finding the missing heritability of complex diseases","volume":"461","author":"Manolio","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2020.09.038_bib59","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/cge.12257","article-title":"A\u00a0systematic approach to assessing the clinical significance of genetic variants","volume":"84","author":"Duzkale","year":"2013","journal-title":"Clin Genet"},{"key":"10.1016\/j.ajog.2020.09.038_bib60","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/gim.2016.90","article-title":"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples","volume":"19","author":"Walsh","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.ajog.2020.09.038_bib61","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1182\/blood-2008-03-144691","article-title":"Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome","volume":"112","author":"Fakhouri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2020.09.038_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort","volume":"8","author":"Salmon","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajog.2020.09.038_bib63","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.3109\/14767058.2012.694923","article-title":"The genetics of the alternative pathway of complement in the pathogenesis of HELLP syndrome","volume":"25","author":"Crovetto","year":"2012","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.09.038_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117840","article-title":"Genetic analysis of membrane cofactor protein (CD46) of the complement system in women with and without preeclamptic pregnancies","volume":"10","author":"Lokki","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2020.09.038_bib65","doi-asserted-by":"crossref","first-page":"e99128","DOI":"10.1172\/jci.insight.99128","article-title":"Germline mutations in the alternative pathway of complement predispose to HELLP syndrome","volume":"3","author":"Vaught","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ajog.2020.09.038_bib66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.preghy.2018.02.007","article-title":"Thrombotic microangiopathies of pregnancy: differential diagnosis","volume":"12","author":"Gupta","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2020.09.038_bib67","first-page":"624","article-title":"Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS","volume":"111","author":"Fang","year":"2008","journal-title":"C3 glomerulonephritis, and the HELLP syndrome. Blood"},{"key":"10.1016\/j.ajog.2020.09.038_bib68","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1371\/journal.pgen.0030041","article-title":"Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome","volume":"3","author":"Zipfel","year":"2007","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ajog.2020.09.038_bib69","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1182\/blood-2009-02-205641","article-title":"Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation","volume":"114","author":"Heinen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2020.09.038_bib70","first-page":"551","article-title":"Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid","volume":"73","author":"Haeger","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.09.038_bib71","doi-asserted-by":"crossref","first-page":"385.e1","DOI":"10.1016\/j.ajog.2007.10.793","article-title":"Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia","volume":"198","author":"Lynch","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.09.038_bib72","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1471-0528.2009.02473.x","article-title":"The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia","volume":"117","author":"Lynch","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2020.09.038_bib73","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/AOG.0b013e3181fc3afa","article-title":"Early elevations of the complement activation fragment C3a and adverse pregnancy outcomes","volume":"117","author":"Lynch","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.09.038_bib74","doi-asserted-by":"crossref","first-page":"428.e1","DOI":"10.1016\/j.ajog.2012.02.035","article-title":"Prepregnancy obesity and complement system activation in early pregnancy and the subsequent development of preeclampsia","volume":"206","author":"Lynch","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.09.038_bib75","doi-asserted-by":"crossref","first-page":"263109","DOI":"10.1155\/2015\/263109","article-title":"Complement split products in amniotic fluid in pregnancies subsequently developing early-onset preeclampsia","volume":"2015","author":"Banadakoppa","year":"2015","journal-title":"Dis Markers"},{"key":"10.1016\/j.ajog.2020.09.038_bib76","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molimm.2020.03.021","article-title":"Dysregulation of complement system during pregnancy in patients with preeclampsia: a prospective study","volume":"122","author":"He","year":"2020","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib77","first-page":"698","article-title":"Enhanced anaphylatoxin and terminal C5b-9 complement complex formation in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelet count","volume":"76","author":"Haeger","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.09.038_bib78","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3109\/14767050903301009","article-title":"Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products","volume":"23","author":"Soto","year":"2010","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.09.038_bib79","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/HYPERTENSIONAHA.113.01420","article-title":"Urinary excretion of C5b-9 in severe preeclampsia: tipping the balance of complement activation in pregnancy","volume":"62","author":"Burwick","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.09.038_bib80","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/aji.12586","article-title":"Complement component C1q as potential diagnostic but not predictive marker of preeclampsia","volume":"76","author":"Agostinis","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib81","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/aji.12541","article-title":"Expression of the complement system\u2019s activation factors in plasma of patients with early\/late-onset severe pre-eclampsia","volume":"76","author":"He","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib82","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/AOG.0000000000002980","article-title":"Terminal complement activation in preeclampsia","volume":"132","author":"Burwick","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.09.038_bib83","doi-asserted-by":"crossref","first-page":"269.e1","DOI":"10.1016\/j.ajog.2019.06.024","article-title":"Assessment of blood-brain barrier integrity and neuroinflammation in preeclampsia","volume":"221","author":"Burwick","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.09.038_bib84","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1073\/pnas.78.3.1818","article-title":"Molecular weight of the membrane C5b-9 complex of human complement: characterization of the terminal complex as a C5b-9 monomer","volume":"78","author":"Bhakdi","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajog.2020.09.038_bib85","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1681\/ASN.2011111072","article-title":"C3a and C5a promote renal ischemia-reperfusion injury","volume":"23","author":"Peng","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ajog.2020.09.038_bib86","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI8621","article-title":"Predominant role for C5b-9 in renal ischemia\/reperfusion injury","volume":"105","author":"Zhou","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2020.09.038_bib87","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.114.03456","article-title":"Complement activation and kidney injury molecule-1-associated proximal tubule injury in severe preeclampsia","volume":"64","author":"Burwick","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2020.09.038_bib88","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4049\/jimmunol.143.2.546","article-title":"Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy","volume":"143","author":"Kerjaschki","year":"1989","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib89","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1681\/ASN.V114700","article-title":"Complement activation products in the urine from proteinuric patients","volume":"11","author":"Morita","year":"2000","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ajog.2020.09.038_bib90","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/aji.12349","article-title":"Urinary excretion of C5b-9 is associated with the anti-angiogenic state in severe preeclampsia","volume":"73","author":"Guseh","year":"2015","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib91","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0161-5890(96)00078-8","article-title":"Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv","volume":"33","author":"Thomas","year":"1996","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib92","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.09.038_bib93","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.09.038_bib94","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1469-1809.2009.00554.x","article-title":"Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome","volume":"74","author":"Sullivan","year":"2010","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.ajog.2020.09.038_bib95","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1056\/NEJMoa1502950","article-title":"Eculizumab in pregnant patients with paroxysmal nocturnal hemoglobinuria","volume":"373","author":"Kelly","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.09.038_bib96","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1182\/blood-2009-03-195966","article-title":"How I treat paroxysmal nocturnal hemoglobinuria","volume":"113","author":"Brodsky","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2020.09.038_bib97","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.imbio.2014.11.003","article-title":"Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn","volume":"220","author":"Hallstensen","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.ajog.2020.09.038_bib98","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.exphem.2016.01.005","article-title":"Direct evidence of complement activation in HELLP syndrome: a link to atypical hemolytic uremic syndrome","volume":"44","author":"Vaught","year":"2016","journal-title":"Exp Hematol"},{"key":"10.1016\/j.ajog.2020.09.038_bib99","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2215\/CJN.05830519","article-title":"Complement activation and thrombotic microangiopathies","volume":"14","author":"Palomo","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ajog.2020.09.038_bib100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.placenta.2012.11.014","article-title":"Eculizumab for the treatment of preeclampsia\/HELLP syndrome","volume":"34","author":"Burwick","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2020.09.038_bib101","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/AOG.0000000000003570","article-title":"Pregnancy prolongation after eculizumab use in early-onset preeclampsia","volume":"134","author":"Lu","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.09.038_bib102","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3389\/fimmu.2020.00548","article-title":"Eculizumab treatment for postpartum HELLP syndrome and aHUS-case report","volume":"11","author":"Lokki","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajog.2020.09.038_bib103","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1182\/blood-2014-07-589366","article-title":"Eculizumab fails to inhibit generation of C5a in\u00a0vivo","volume":"124","author":"Burwick","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2020.09.038_bib104","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2012-02-412080","article-title":"Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway","volume":"120","author":"Krisinger","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2020.09.038_bib105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1182\/blood-2015-06-642553","article-title":"Response: maternal and cord C5a in response to eculizumab","volume":"126","author":"Burwick","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2020.09.038_bib106","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1681\/ASN.2011121186","article-title":"Pathology after eculizumab in dense deposit disease and C3 GN","volume":"23","author":"Herlitz","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820311297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820311297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:33:35Z","timestamp":1757590415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937820311297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":106,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0002937820311297"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2020.09.038","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2020.09.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}